Evidence map›Paper›PMID 36790207›Full record

ArticleNeurosurgery2023

Risk of Tract Seeding Following Laser Interstitial Thermal Therapy for Brain Tumors.

Aden P Haskell-Mendoza, Ethan S Srinivasan, Emily C Lerner, Ryan M Edwards, Allison M Schwalb, Joshua D Jackson, Andrew A Hardigan, Eugene J Vaios, Peter E Fecci

Open access · greenAbstract read
In one paragraph

Article in Neurosurgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Aden P Haskell-MendozaDuke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-9186-7261
Ethan S SrinivasanDuke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-9892-5866
Emily C LernerDuke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0003-1597-8581
Ryan M EdwardsDuke University School of Medicine, Durham, North Carolina, USA.
Allison M SchwalbDuke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-1905-8988
Joshua D JacksonDepartment of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Andrew A HardiganDepartment of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Eugene J VaiosDuke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0003-2122-6650
Peter E FecciDuke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-2912-8695
Duke University · USDuke Medical Center · USJohns Hopkins University · US

Funding

Duke Radiation Oncology and Radiology Stimulating Access to Research in ResidencyR38CA245204 · NCI · DUKE UNIVERSITY · PI FLOYD, SCOTT R · 2020 to 2023
$1.4M
NCI NIH HHS R38 CA245204
6 · The paper itself

Abstract

backgroundThe management of intracranial oncological disease remains a significant challenge despite advances in systemic cancer therapy. Laser interstitial thermal therapy (LITT) represents a novel treatment for local control of brain tumors through photocoagulation with a stereotactically implanted laser fiber. Because the use of laser interstitial thermal therapy continues to increase within neurosurgery, characterization of LITT is necessary to improve outcomes.

objectiveTo quantify the risk of tumor seeding along the laser fiber tract in patients receiving LITT for primary or metastatic brain tumors at a high-volume treatment center.

methodsWe retrospectively reviewed all patients receiving LITT from 2015 to 2021 at our medical center. Patients with biopsy-confirmed tumors were included in this study. Tract seeding was identified as discontinuous, newly enhancing tumor along the LITT tract.

resultsFifty-six patients received LITT for biopsy-confirmed tumors from 2015 to 2021, with tract seeding identified in 3 (5.4%). Twenty-nine (51.8%) patients had gliomas, while the remainder had metastases, of which lung was the most common histology (20 patients, 74%). Tract seeding was associated with ablation proceeding inward from superficial tumor margin closest to the cranial entry point ( P = .03). Patients with tract seeding had a shorter median time to progression of 1.1 (0.1-1.3) months vs 4.2 (2.2-8.6) months ( P = .03).

conclusionAlthough the risk of tract seeding after LITT is reassuringly low, it is associated with decreased progression-free survival. This risk may be related to surgical technique or experience. Follow-up radiosurgery to the LITT tract has the potential to prevent this complication.

Indexed as

Brain NeoplasmsLaser TherapyHumansLasersProgression-Free SurvivalRetrospective Studies

Identifiers

PMID36790207
PMCPMC10553123
OpenAlexW4320855978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.